Home » Topics » Disease categories and therapies » Urology

Urology
RSS

AVE-7688 provides renal protection in diabetes model

Nov. 29, 2004

Vesicare approved by FDA

Nov. 24, 2004

Gabapentin delays ejaculation in a case of PE / News in Context

Nov. 24, 2004

Darifenacin shows efficacy in the treatment of women with overactive bladder

Nov. 19, 2004

NH3 exchange inhibitors and their use described by Aventis

Nov. 19, 2004

CYC-202 as potential new treatment for lupus nephritis

Nov. 16, 2004

Orphan drug designation for CR-002 in IgA nephropathy

Nov. 15, 2004

Orphan drug status for intravenous terlipressin for type 1 hepatorenal syndrome

Nov. 12, 2004

Acute renal injury in anti-GBM glomerulonephritis acts via a JNK-dependent mechanism

Nov. 11, 2004

Discontinuation of phase II pamirosin trial for BPH

Nov. 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...